期刊文献+

LY294002对套细胞淋巴瘤增殖、凋亡及Notch1信号通路的影响 被引量:5

Effects of LY294002 on Proliferation,Apoptosis and Notch1 Signal Pathway of Mantle Cell Lymphoma
下载PDF
导出
摘要 目的观察磷脂酰肌醇3-激酶/丝氨酸苏氨酸激酶(PI3K/Akt)特异性抑制剂LY294002对人套细胞淋巴瘤Jeko-1细胞株细胞增殖、凋亡及Notch1信号通路的影响。方法四甲基偶氮唑盐(MTT)法检测细胞增殖抑制率;流式细胞仪检测细胞凋亡变化;Western blot检测凋亡相关蛋白Bcl-2、Bax、Caspase-3、Caspase-9及信号通路相关蛋白pAkt、Notch1、HES1的变化。结果 LY294002能明显抑制Jeko-1细胞的增殖;经0、5、10和20μmol/L的LY294002作用24h后,Jeko-1细胞的凋亡率分别为(3.25±1.27)%、(11.34±2.35)%、(22.81±2.74)%、(43.61±3.48)%,差异有统计学意义(P<0.01);Western blot检测发现凋亡相关蛋白Bcl-2表达下降,Bax、Caspase-3、Caspase-8、Caspase-9表达上升,PI3K/Akt信号通路相关蛋白p-Akt磷酸化水平下降,Notch1信号通路相关蛋白Notch1、HES1表达下降。结论LY294002可以特异性抑制PI3K/Akt信号通路,也可下调Notch1信号通路的活性,抑制Jeko-1细胞增殖,促进细胞凋亡。 Objective To investigate the effects of the specific inhibitor of phosphatidylinositol 3-kinase/Akt(PI3K/Akt),LY294002,on the proliferation and apoptosis of Jeko-1cell line of mantle cell lymphoma(MCL),and on the expressions of Notch1 signaling pathway-related proteins.Methods Jeko-1cells were cultured with different concentrations of LY294002.Cell growth was determined by MTT.Cell apoptosis was analyzed by flow cytometry.The expressions of apoptosis-related proteins(Bcl-2,Bax,Caspase-3and Caspase-9)and Notch1 signaling pathway-related proteins(p-Akt,Notch1 and HES1)were detected by Western blot.Results LY294002 could inhibit the proliferation of Jeko-1cells in a time-and dose-dependent manner.The cell apoptotic rates of Jeko-1cells treated with 0,5,10 and 20μmol/L of LY294002 for 24h were(3.25±1.27)%,(11.34±2.35)%,(22.81±2.74)% and(43.61±3.48)%,respectively,and there were significant differences(P0.01).Western blot showed that the expression of Bcl-2 was down-regulated,those of Bax,Caspase-3,Caspase-8and Caspase-9up-regulated,the phosphorylation level of the PI3K/Akt signaling pathway-related protein p-Akt decreased and the expressions of Notch1 signaling pathway-related proteins Notch1 and HES1reduced.Conclusion LY294002 can suppress the growth and induce the apoptosis of Jeko-1cells by specifically inhibiting the PI3K/Akt signaling pathway and down-regulating the activity of Notch1 signaling pathway.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2015年第2期156-159,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 福建省引进重大研发机构资助项目(No.2012I2004)
关键词 LY294002 磷脂酰肌醇3-激酶/丝氨酸苏氨酸激酶 套细胞淋巴瘤 Notch1信号通路 增殖 凋亡 LY294002 phosphatidylinositol-3-kinase/Akt(PI3K/Akt) mantle cell lymphoma(MCL) Notchl signaling pathway proliferation apoptosis
  • 相关文献

参考文献15

  • 1Snehal M G, Pritha R. Non-invasive imaging of PI3K/Akt/ mTOR signalling in cancer[J]. Am J Nucl Med Mol Imaging, 2012,2 (4) : 418-431. 被引量:1
  • 2Martina R, Stefania P, Satoshi N, et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma[J]. Blood,2006,108(5) :1668-1676. 被引量:1
  • 3Chiaramonte R, Hiaramonte R, Basile A, et al. Wider role for NOTCH1 signaling in acute leukemia I-J]. Cancer Letters, 2005,219(1) .. 113-120. 被引量:1
  • 4Herrmann A, Hoster E, Zwingers T, et al. Improvement o{ o- ver all survival in advanced stage mantle cell lymphoma[J]. J Clin Oncol, 2009,27(4) : 511-518. 被引量:1
  • 5Hixon M L, Paccagnella L, Millham R, et al. Development of inhibitors o{ the IGF-IR/PI3K/Akt/mTOR pathway[J]. Rev Recent Clin Trials, 2010,5 (3) ~ 189-208. 被引量:1
  • 6Kong D, Yamori T. Phosphatidylinositol 3-kinase inhibitors~ promising drug candidates ~or cancer therapy[J]. Cancer Sci, 2008,99(9) ~ 1734-1740. 被引量:1
  • 7Jaclyn L,Gideon M B,Wendy B B,et al. Targeting the PI3K/ Akt/mTOR pathway ~ effective combinations and clinical con- siderations[J]. Drug Resist Updat, 2008,11 (12) ~ 32-50. 被引量:1
  • 8Knowles M A,Platt F M,Ross R L, et al. Phosphatidylinosi- tol 3 kinase(PI3K)pathway activation in bladder cancer[J]. Cancer Metastasis Rev, 2009,28(34) ~ 305-316. 被引量:1
  • 9Courtney K D,Corcoran R B,Engelman J A,et al. The PI3K pathway as drug target in human cancer[J]. J Clin Oncol, 2010,28(6) ~ 1075-1083. 被引量:1
  • 10Carvalho S,Schmitt F. Potential role o{ PI3K inhibitors in the treatment of breast cance[J]. Future Oncol,2010,6(8) ~1251- 1263. 被引量:1

同被引文献48

  • 1孙曼,蒋军广,张晓燕,史江,安金路,楚玉洁,崔永亮,张艳梅.凋亡相关基因caspase-3在非小细胞肺癌中的表达及临床意义[J].中国老年学杂志,2014,34(1):17-19. 被引量:8
  • 2Lin H L, Yang M H, Wu C W, et al. Methoxyest radiol at tenuates phosphatidyl inositol 3-kinase/Akt pathway-mediated metastas is of gastric cancer[J]. Int J Cancer, 2007,121(11): 2547-2555. 被引量:1
  • 3Fang Y, Xue J L, Shen Q, et al. miR-7 inhibits tumor growth and metastasis by targeting the PI3K/Akt pathway in hepatocellular carcinoma[J]. Hepatology, 2012,55(6):1852-1862. 被引量:1
  • 4Guo H, Gao M, Lu Y, et al. Coordinate phosphorylation of multiple residues on single Aktl and Akt2 molecules[J]. Onco- gene, 2013,33(26):3463-3472. 被引量:1
  • 5Lee S, Choi E J, Jin C, et al. Activation of PI3K/Akt path- way by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line[J]. Gynecol Oncol, 2005,97(1):26-34. 被引量:1
  • 6Lee J T Jr, Steelman L S, MeCubrey J A, et al. Phosphati- dylinositol 3"-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistanee in ad- vanced prostate cancer cells[J]. Cancer Res, 2004,64(22):8397- 8404. 被引量:1
  • 7Sui H, Fan Z Z, Li Q. Signal transduction pathways and tran- scriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells[J]. J Int Med Res, 2012,40 (2):426-435. 被引量:1
  • 8Jiao M, Nan K J. Activation of PI3kinase/Akt/HIF-1α path- way contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatoeellular carcinoma[J].Int J Oncol, 2012,40(2):461-468. 被引量:1
  • 9Abdul R, Serra V, Gyorffy B, et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma ceils overexpressing MRPI[J]. Oncogene, 2006,25(12):1743- 1752. 被引量:1
  • 10Ye Q F, Zhang Y C, Peng X Q, et al. shRNA-mediated si- lencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells[J]. Asian Pac J Cancer Prey, 2012,13(6):2485-2489. 被引量:1

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部